2025 Publications

Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. View article. Y Nan, FN Felder, S Humphries, JA Mackintosh, C Grainge, HE Jo, N Goh, PN Reynolds, PMA Hopkins, V Navaratnam, Y Moodley, H Walters, S Ellis, G Keir, C Zappala, T Corte, I Glaspole, AU Wells, G Yang, SLF Walsh. 2025. European Respiratory Journal. 

Investigational insights into the potential of angiotensin type II receptor agonists as therapeutics for idiopathic pulmonary fibrosis. View article. ON Young, RE Widdop, JE Bourke. 2026. Expert Opinion on Investigational Drugs. 

Addressing the inequities in interstitial lung disease care outside specialised centres in Australia. View article. G Tikellis, AE Holland. 2025. Respiratory Medicine Research. 

Interstitial lung disease: multidisciplinary outpatient palliative care service. View article. M Tran, KY Tham, S Webster, L Troy, C Fermoyle, CM Geis, H Jo, A Teoh, L Glenn, N Mortimer, KM Chen, A Thiruvarudchelvan, TJ Corte, A Mohamudally. 2025. BMJ Supportive & Palliative Care. 

CaNO and eCO Might Be Potential Non-Invasive Biomarkers for Disease Severity and Exacerbations in Interstitial Lung Disease. View article. Y Zhang, F Wang, M Zhu, Y Zhang, L Xu, L Li, P Li, Q Xie, X Lv, J Yu, Y Moodley, H Wan, H Mao, F Luo. 2025. Journal of Clinical Medicine. 

Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosis. View article. OC Leavy, AF Goemans, T Hernandez-Beeftink, AD Stockwell, RJ Allen, R Guillen-Guio, A Adegunsoye, HL Booth, WA Fahy, TE Fingerlin, HS Virk, IP Hall, SP Hart, MR Hill, N Hirani, N Kaminski, SF Ma, RJ Mcanulty, XR Sheng, AB Millar, M Molina-Molina, V Navaratnam, M Neighbors, H Parfrey, G Saini, I Sayers, ME Strek, MD Tobin, MKB Whyte, Y Zhang, TM Maher, PL Molyneaux, JM Oldham, BL Yaspan, C Flores, F Martinez, CJ Reynolds, DA Schwartz, I Noth, RG Jenkins, LV Wain. 2025. ERJ Open Research.

Inhalational exposures associated with risk of interstitial lung disease: a systematic review and meta-analysis. View article. CT Lee, SA Gandhi, S Elmrayed, H Barnes, D Lorenzetti, ML Salisbury, ID Stewart, C Barber, CE Peters, J Feary, KA Johannson. 2025. Thorax. 

The role of epigenetic regulation in idiopathic pulmonary fibrosis. View article. RM Li, M Stentenbach, DBA Tan, HP Ludewick, EH Walters, B Clynick, YP Moodley. 2026. American Journal of Physiology Lung Cellular and Molecular Physiology. 

Generation of a novel lung fibrosis model using precision-cut lung slices from transgenic TGFbeta1 mice. View article. Y Liu, PC Papagianis, ZSC De Kuijper, JG Chitty, B Thomas, T Borghuis, RM Jongman, J Pillay, EA Richards, BN Melgert, JK Burgess, JE Bourke. 2025. American Journal of Physiology – Cell Physiology. 

Global epidemiology and burden of interstitial lung disease. View article. P Spagnolo, SA Guler, N Chaudhuri, Z Udwadia, L Sese, B Kaul, JI Enghelmayer, C Valenzuela, A Malhotra, CJ Ryerson, YH Khor, TJ Corte, V Cottin. 2025. The Lancet Respiratory Medicine. 

Let-7f-5p Has Antifibrotic Properties and Is Reduced in Circulatory Small Extracellular Vesicles in Progressive Idiopathic Pulmonary Fibrosis. View article. DBA Tan, M Stentenbach, E Bolitho, C Tedja, E Aresgado, CH Chen, A Linderholm, J Oldham, Y Moodley. 2025. American Journal of Respiratory and Critical Care Medicine. 

Likelihood of Usual Interstitial Pneumonia: A Novel Approach to Prognosis for Pulmonary Fibrosis. View article. JA Mackintosh, SLF Walsh, M Silva, L Calandriello, SM Humphries, DA Lynch, HE Jo, I Glaspole, C Grainge, N Goh, PMA Hopkins, Y Moodley, PN Reynolds, C Zappala, G Keir, WA Cooper, AM Mahar, S Ellis, AU Wells, TJ Corte. 2026. Respirology. 

J Mann, H Barnes, J Lew, YH Khor, N Goh, AE Holland. 2025. European Respiratory Review. Patient-reported outcome measures for cough used in interstitial lung disease: a systematic review. View article.

Interstitial lung abnormalities: challenges and opportunity. View article. Y Moodley. 2025. The Lancet Respiratory Medicine. 

Interstitial lung abnormality discovery: A path to early intervention for interstitial lung disease. View article. S Shivakumar, CH Leong, N Goh. 2025. Respiratory Medicine Today. 

Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis. View article. M Kolb, TJ Corte, J Feldman, SD Nathan, C Reisner, D Nair, F Woodhead, H Lazarus, C Conoscenti. 2025. BMJ Open Respiratory Research. 

Clinical Features Associated With Fatigue in People With Fibrotic Interstitial Lung Disease: Cross-Sectional Study. View article. S Kawachi, M Hoffman, AE Holland. 2025. Respirology. 

Treatable traits in interstitial lung disease: opportunities and challenges. View article. YH Khor, AJ Podolanczuk, EA Renzoni, VM Mcdonald, V Cottin, AE Holland, Y Inoue, AM Russell, JW Song, M Wijsenbeek, ME Strek, CJ Ryerson. 2025. Respiratory Medicine. 

Myeloperoxidase-Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series. View article. M Hoskins, G Thompson, V Navaratnam. 2025. Respirology Case Reports. 

What are the important components of physical activity for people with fibrotic interstitial lung disease? View article. M Hoffman, CR Mellerick, AT Burge, AE Holland. 2025. Chronic Respiratory Disease. 

The impact of oral anticoagulants on idiopathic pulmonary fibrosis risk and prognosis: a population study. View article. F Gonnelli, H Heatley, U Smith, N Eleangovan, V Navaratnam, J Townend, TJ Corte, DB Price, V Carter, M Bonifazi, CC Fermoyle, R Hubbard. 2025. European Respiratory Journal. 

Osteoprotegerin Is Elevated in Pulmonary Fibrosis and Associates with Idiopathic Pulmonary Fibrosis Progression: A Pilot Study. View article. H Habibie, KSS Putri, CE Boorsma, DM Brass, P Heukels, M Wijsenbeek, M Kool, M Van Den Berge, T Borghuis, A Vaughan, T Corte, G Liu, CA Brandsma, CT Gan, P Olinga, W Timens, N Kahn, PM Hansbro, M Kreuter, JK Burgess, BN Melgert. 2025. Respiration. 

Do we need to prioritise interstitial lung disease clinical diagnoses? A comment on the 2025 interstitial pneumonia statement. View article. A Fraser, LL Tsai, CC Fermoyle, N Mortimer, L Troy, J Mackintosh, DC Chambers, N Goh, D Milne, J Wrobel, M Wilsher, S De Boer, MJS Parker, S Webster, A Baker, T Hyde, J Alison, TJ Corte. 2026. European Respiratory Journal. 

Patient and healthcare professional perspectives on telehealth in the care of interstitial lung disease. View article. S Deshpande, G Tikellis, H Barnes, YH Khor, K Symons, AE Holland, I Glaspole. 2025. Chronic Respiratory Disease. 

What’s new in PF treatment. View article. S Deshpande, I Glaspole. 2025. MJA Insight. 

Matrix Softness Induces an Afibrogenic Lipofibroblast Phenotype in Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis. View article. A Berhan, A Gunatilaka, C Lee, S Zhang, D Tan, T Harris, J Jaffar, F Jativa, I Lonnstedt, M Alhamdoosh, M Ng, S Langenbach, S Varshney, NA Williamson, PVS Lee, N Wilson, B Gao, G Westall, AG Stewart. 2025. American Journal of Respiratory Cell and Molecular Biology. 

A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocol. View article.C Barton, M Hoffman, NS Cox, LM Glenn, JYT Lee, I Cox, NSL Goh, LK Troy, J Mackintosh, DC Chambers, IN Glaspole, V Gebski, A Keech, A Palmer, L Laranjo, LD Knibbs, Y Moodley, M Brooke, AE Holland, TJ Corte. 2025. Respiratory Research. 

Specific content for education and self-management programmes for people with pulmonary fibrosis: a co-creation, multiphase, mixed-method study. View article. TF Riegler, A Frei, M Wirz, AE Holland, K Lindell, P Brun, MA Puhan, T Marcin, SA Guler, PH Group. 2025. ERJ Open Research.

Iron Alters the Transcriptome and Volatile Organic Compounds in the BAL of Patients with Silicosis. View article. CA Aloe, NSL Goh, H Wang, JL McQualter, SNE Doomun, D De Souza, R Pujari, PC Papagianis, SH Apte, H Barnes, R Vlahos, CF McDonald, RF Hoy, DC Chambers, TL Leong, S Bozinovski. 2025. American Journal of Respiratory Cell and Molecular Biology.  

Nerandomilast in Patients with Progressive Pulmonary Fibrosis. View article. TM Maher, S Assassi, A Azuma, V Cottin, A Hoffmann‑Vold, M Kreuter, JM Oldham, L Richeldi, C Valenzuela, MS Wijsenbeek, E Clerisme‑Beaty, C Coeck, H Gu, I Ritter, A Schlosser, S Stowasser, F Voss, G Weimann, DF Zoz, Fernando J Martinez, for the FIBRONEER-ILD Trial Investigators. 2025. New England Journal of Medicine.

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis. View article. L Richeldi, A Azuma, V Cottin, M Kreuter, TM Maher, FJ Martinez, JM Oldham, C Valenzuela, E Clerisme‑Beaty, M Gordat, D Wachtlin, Y Liu, C Schlecker, S Stowasser, DF Zoz, MS Wijsenbeek, for the FIBRONEER-IPF Trial Investigators. (FIBRONEER-IPF Trial Investigators includes I. Glaspole, N. Goh, J. Wrobel, T. Corte, D. Chambers, G. Keir, J. Mackintosh.). 2025. New England Journal of Medicine. 

Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement. View article. Anna J Podolanczuk, Gary M Hunninghake, Kevin C Wilson, Yet H Khor, Fayez Kheir, Brandon Pang, Ayodeji Adegunsoye, Gretchen Cararie, Tamera J Corte, Jim Flanagan, Gunnar Gudmundsson, Lida P Hariri, Hiroto Hatabu, Stephen M Humphries, Bhavika Kaul, John S Kim, Melanie Konigshoff, Jonathan A Kropski, Joyce S Lee, Fengming Luo, David A Lynch, Fernando J Martinez, Sydney B Montesi, Yuben Moodley, Justin M Oldham, Sara Piciucchi, Rachel K Putman, Luca Richeldi, Ivan O Rosas, Margaret L Salisbury, Mary M Salvatore, Moises Selman, Joon Beom Seo, Jin Woo Song, Carey C Thomson, Marina Vivero, Louise V Wain, Marlies Wijsenbeek, David A Schwartz, Christopher J Ryerson, 2025, American Journal of Respiratory and Critical Care Medicine.  

Patients with idiopathic pulmonary fibrosis have fatty lungs impacting respiratory physiology. View article. Wenying Lu, Affan Mahmood Shahzad, Josie Larby, Maddison Waters, Maddison, Melinda Wilson, Jade Jaffar, Glen Westall, Darren Sutherland, Greg Haug, Tille L. Hackett,  Sukhwinder Singh Sohal, 2025, Pulmonology.

The interstitial lung disease patient pathway: from referral to diagnosis. View article. Graham Lough, Rayid Abdulqawi, Gina Amanda, Katerina Antoniou, Arata Azuma, Milind Baldi, Ahmed Bayoumy,  Jürgen Behr, Elisabeth Bendstrup, Demosthenes Bouros, Kevin Brown, Nazia Chaudhuri, Tamera J. Corte, Vincent Cottin, Bruno Crestani, Kevin R. Flaherty, Ian Glaspole, Leticia Kawano-Dourado, Michael P. Keane, Martin Kolb, Fernando J. Martinez, Maria Molina-Molina, Iñigo Ojanguren, Laurence Pearmain, Ganesh Raghu, Paola Rottoli, Stefan Stanel, Gabriela Tabaj, Carlo Vancheri, Brenda Varela, Bonnie Wang, Athol Wells, Pila Rivera-Ortega, 2025, ERJ Open Research.

Pathophysiology of small airways in idiopathic pulmonary fibrosis (IPF): the silent zone. View article. Wenying Lu, Affan Mahmood Shahzad, Athul Antony Simon, Greg Haug, Maddison Waters, Sukhwinder Singh  Sohal, 2025, Expert Review of Respiratory Medicine.

CD131 antagonism blocks inflammation, emphysema and fibrosis in an asthma-COPD overlap mouse model originating in early life. View article. Hao Wang, Nok Him Fung, Christian Aloe, Mark Miles, Stavros Selemidis, Angel F. Lopez, Nick Wilson, Catherine Owczarek, Steven Bozinovski, 2025, Respirology.

Cough monitoring systems in adults with chronic respiratory diseases: a systematic review. View article. Latisha E. Witjaksono, Max Schulte, Anne E. Holland, Marlies S. Wijsenbeek, Yet H. Khor, 2025, European Respiratory Review.

The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project. View article. Giovanni Zanframundo, Eduardo Dourado, Iazsmin Bauer-Ventura, Sara Faghihi-Kashani, Akira Yoshida, Aravinthan Loganathan,  Daphne Rivero-Gallegos, Darosa Lim, Francisca Bozán, Gianluca Sambataro, Sangmee Sharon Bae, Yasuhiko Yamano, Francesco Bonella, Tamera J. Corte et al., 2025, Annals of the Rheumatic Diseases.

The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis. View article. Anuradha Bishnoi, Iris Yan Ki Tang, Akira Yoshida, Faye M. Pais, Sabeena Y. Usman, Solciris Dominguez, Chengappa G. Kavadichanda, Daphne Rivero-Gallegos, Eduardo  Dourado, Edoardo Conticini, Francisca Bozán, Gayathri Tulluru, James B. Lilleker, Kaushik Sreerama Reddy, Océane Landon-Cardinal, Rachid Smaili, Shiri Keret,  Thomas Khoo, Ting-Yuan Lan, Valérie Leclair, Chester V. Oddis, Jiří Vencovský, Masataka Kuwana, Prateek C. Gandiga, Rohit Aggarwal, Olivier Benveniste, Daniel Brito de Araujo, Christina Charles-Schoeman, Hector Chinoy, Tamera J. Corte, et al., 2025, Clinical and Experimental Rheumatology.

Pathology of idiopathic pulmonary fibrosis with particular focus on vascular endothelium and epithelial injury and their therapeutic potential. View article. Wenying  Lu, Alan Teoh, Maddison Waters, Greg Haug, Ilma Shakeel, Imtaiyaz Hassan, Affan Mahmood Shahzad, Anna-Karin Larsson Callerfelt, Lucilla Piccari, Sukhwinder Singh Sohal, 2025, Pharmacology and Therapeutics.

Treatable traits in interstitial lung disease: a narrative review. View article. Megan Harrison, Chloe Lawler, Fiona Lake, Vidya Navaratnam, Caitlin Fermoyle, Yuben Moodley, Tamera J. Corte, 2025, Therapeutic Advances in Respiratory Disease.

Unravelling Granulomatous-Lymphocytic Interstitial Lung Disease: A Case of Common Variable Immunodeficiency With Unusual Clinical Features and Response to Intravenous Immunoglobulin. View article. Nirosha Pragash, Jennifer Mann, Anton Antonov, 2025, Respirology Case Reports.

Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis A Phase 2 Randomized Clinical Trial. View article. Tamera J. Corte, Juergen Behr, Vincent Cottin, Marilyn K. Glassberg, Michael Kreuter, Fernando J. Martinez, Takashi Ogura, Takafumi Suda, Marlies Wijsenbeek, Elchonon Berkowitz, Brandon  Elpers, Sinae Kim, Hideaki Watanabe, Aryeh Fischer, Toby M. Maher, 2025, American Journal of Respiratory and Critical Care Medicine. 

Supplemental oxygen for symptomatic relief in people with serious respiratory illness: a systematic review and meta-analysis. View article. Zainab Ahmadi, Natasha E Smallwood, Anne-Marie Russell, Ravijyot Saggu, Lorena Romero, Anne E Holland, Magnus Ekström, 2025, European Respiratory Review.

Geographic variability of interstitial lung disease diagnoses and impact of air pollution on disease outcomes. View article. Annalise Bagust, Cheng Zhao, Lauren Troy, Joe Van Buskirk, Astrid Gardiner, Megan Harrison, Nathan Mortimer, Luke D Knibbs, Tamera J Corte, 2025, Respiratory Medicine. 

Reply: A recommendation for increased airflow to relieve breathlessness: evidence in context is a strength of the GRADE approach. View article. Anne E Holland, Claudia Bausewein, Natasha Smallwood, Magnus Ekström, 2025, European Respiratory Journal.

Early, integrated palliative care for people with chronic respiratory disease: lessons learnt from lung cancer. View article. Anne M. Walker, Donald R. Sullivan, Phan Nguyen, Anne E. Holland, Natasha Smallwood, 2025, Therapeutic Advances in Respiratory Disease. 

Transcriptomic Plasticity of Human Alveolar Macrophages Revealed by Single-Cell RNA Sequencing Following Drug Exposure: Implications for Therapeutic Development. View article. Penny L Groves, Levi Hockey, Brendan J O’Sullivan, Lai-Ying Zhang, Zherui Xiong, Quan H Nguyen, Maxine E Tan, Viviana P Lutzky, Rohan A Davis, Daniel C Chambers, Simon H Apte, 2025, International Journal of Molecular Sciences.

Incidence and survival of interstitial lung diseases in the UK in 2010–2019. View article. Francesca Gonnelli, Neva Eleangovan, Ursie Smith, Heath Heatley, Vidya Navarantam, Tamera J Corte, David B Price, Victoria Carter, Martina Bonifazi, Caitlin C Fermoyle, Richard Hubbard, 2025, ERJ Open Research.

Challenges of symptom management in interstitial lung disease: dyspnea, cough, and fatigue. View article. Amy Pascoe, Anne E Holland, Natasha Smallwood, 2025, Expert Review of Respiratory Medicine.

The changing role of opioids for symptom management in people with advanced lung disease. View article. Amy Pascoe, Natasha Smallwood, 2025, Expert Review of Respiratory Medicine.

Incidence of acute exacerbations of chronic respiratory disease during pulmonary rehabilitation delivered at home or hospital. View article. Angela T Burge, Narelle S Cox, Arkash Ponnudurai, Anne E Holland, Janet Bondarenko, Catherine J Hill, Arwel W Jones, 2025, ERJ Open Research.

Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review. View article. Amy Pascoe, Xinye Esther Chen, Natasha Smallwood, 2025, European Respiratory Review.

The weight of air: a Commission on palliative care integration in serious respiratory illness. View article. William E Rosa, Afsan Bhadelia, Gemma Bowsher, Mark Dransfield, Anand S Iyer, Felicia Marie Knaulf, Kathleen Lindell, Matthew Maddocks, Christian Ntizimira, Obianuju Ozoh, Pedro E Pérez-Cruz, Lukas Radbruch, Smriti Rana, Anne-Marie Russell, Mac Skelton, Natasha Smallwood, Samuel Byiringiro, Jeffersson Santos, Donald R Sullivan, 2025, The Lancet Respiratory Medicine.

Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD (RE-BUILD) pilot study. View article. Laura M Glenn, Dan Jackson, Carly Barton, Doris Lan, Lisa Fuhrmeister, Karen Symons, Louise Turnour, Ben Tefay, Anne E Holland, Nicole S L Goh, Lauren K Troy, Mark Brooke, Ian N Glaspole, Tamera J Corte, 2025, Respirology.

Assessment of Home-based Monitoring in Adults with Chronic Lung Disease An Official American Thoracic Society Research Statement. View article. Yet H Khor, Vitalii Poberezhets, Russell G Buhr, James D Chalmers, Hayoung Choi, Vincent S Fan, Maureen George, Anne E Holland, et al., 2025, American Journal of Respiratory and Critical Care Medicine.

Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project. View article. Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza, Aravinthan Loganathan, Eduardo Dourado, Gianluca Sambataro, Iazsmin Bauer-Ventura, Sangmee Sharon Bae, Darosa Lim, Daphne Rivero-Gallegos, Yasuhiko Yamano, Albert Selva-O’Callaghan, Andrew L Mammen, Carlo A Scirè, Carlomaurizio Montecucco, Chester V Oddis, David Fiorentino, Francesco Bonella, Frederick W Miller, Ingrid E Lundberg, Jens Schmidt, Jorge Rojas-Serrano, Marie Hudson, Masataka Kuwana, Miguel Angel González-Gay, Neil McHugh, Tamera J Corte et al., 2025, Arthritis and Rheumatology.

Remote assessment of exercise capacity in adults with chronic respiratory disease: Safety, reliability and acceptability. View article. Narelle S Cox, Simone Dal Corso, Angela T Burge, Janet Bondarenko, Jaycie Perryman, Anne E Holland, 2025, Chronic Respiratory Disease. 

Phase 2 study design and analysis approach for BBT-877: An autotaxin inhibitor targeting idiopathic pulmonary fibrosis. View article. Toby Maher, Jin Woo Song, Mordechai Reuven Kramer, Lisa Lancaster, Tamera J Corte, Jeong Yun, KyungJin Kim, Jimin Cho, Luisa Fernanda Sather, Peter M George, Anand Devaraj 9, Jin Hyuk Jung, Sujin Jung, 2025, BMJ Open Respiratory Research.

Advances in management of pulmonary fibrosis. View article. Julia A Lachowicz, Daniel P Steinfort, Natasha E Smallwood, Jyotika D Prasad, 2025, Internal Medicine Journal.

A Comprehensive Review of Interstitial Lung Abnormalities. View Article. Yuben Moodley, John A Mackintosh, 2025, Respirology.

Health disparities and associated social determinants of health in interstitial lung disease: a narrative review. View article. Gabriella Tikellis, Anne E Holland, 2025, European Respiratory Review.

Pre-Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. View article. Roger M Li, Dino B A Tan, Chantalia Tedja, Wendy A Cooper, Helen E, Christopher Grainge, Ian N Glaspole, Nicole Goh, Samantha Ellis, Peter M A Hopkins, Christopher Zappala, Gregory J Keir, Paul N Reynolds, Sally Chapman, E Haydn Walters, Darryl Knight, Svetlana Baltic, HuiJun Chih, Tamera J Corte, Yuben P Moodley, 2025, Respirology.

Impact of pulmonary rehabilitation on survival in people with interstitial lung disease. View article. LM. Dowman, B Vainshelboim, AE Holland, 2025, Chest. 

Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease. View article. KA Johannson, A Adegunsoye, J Behr, V Cottin, AR Glanville, MK Glassberg, GC Goobie, RG Jenkins, JS Kim, CT Lee, CA Redlich, L Richeldi, ML Salisbury, T Tetley and TJ Corte, 2025, American Journal of Respiratory and Critical Care Medicine. 

Early, integrated palliative care for people with chronic respiratory disease: lessons learnt from lung cancer. View article. Walker, DR. Sullivan, P. Nguyen, AE. Holland, N. Smallwood. 2025. Ther Adv Respir Dis.